Post-CEA Surveillance Strategy

Standard Surveillance Protocol

• The American College of Cardiology recommends initial post-CEA duplex ultrasound at 1 month post-procedure to establish a baseline 1, 2
• Follow-up imaging is recommended at 6 months after the procedure to assess patency and exclude the development of new or contralateral lesions 1, 2, 3
• Annual surveillance is recommended thereafter to monitor for restenosis and development of contralateral disease 1, 2, 3
• The American College of Cardiology suggests that once stability has been established over an extended period, surveillance intervals may be lengthened 1, 2, 4
• Surveillance may be reasonably terminated when the patient is no longer a candidate for intervention 1, 2

Special Surveillance Considerations

• Patients who have undergone neck radiation therapy have higher rates of restenosis after CAS and may benefit from more frequent monitoring 3, 5
• Patients with risk factors for restenosis, such as diabetes, dyslipidemia, female gender, chronic kidney disease, and smoking, may require more vigilant surveillance 6

Management of Recurrent Stenosis

• The American College of Cardiology recommends that in patients with symptomatic cerebral ischemia and recurrent carotid stenosis, it is reasonable to repeat CEA or perform CAS using the same criteria as recommended for initial revascularization 1, 2, 7
• Reoperative CEA or CAS is reasonable when duplex ultrasound and another confirmatory imaging method identify rapidly progressive restenosis that indicates a threat of complete occlusion 4, 7
• In asymptomatic patients with recurrent stenosis due to intimal hyperplasia or atherosclerosis, reoperative CEA or CAS may be considered using the same criteria as recommended for initial revascularization 7

Adjunctive Medical Therapy During Surveillance

• The American College of Cardiology recommends administration of statin lipid-lowering medication for all patients who have undergone CEA, regardless of serum lipid levels 1, 2, 3
• Long-term antiplatelet therapy should be administered with either aspirin or clopidogrel, or the combination of low-dose aspirin plus extended-release dipyridamole 3, 5
• Blood pressure control is essential both before and after CEA 1, 2